Penn STEM Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Penn STEM Times.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 3, 2026

Mar. 3, 2026

Sciotex Launches Benchtop Automated Inspection Systems to Lower Barriers to AI-Powered Machine Vision

EIN Presswire

Mar. 3, 2026

Dale Laszig’s Blog Series in Vending Times Explores Classic and Modern Payments

EIN Presswire

Mar. 3, 2026

DOM Announces 'Boardroom Ready: A CMO’s Guide to GEO' Webinar on March 25, 2026

EIN Presswire

Mar. 3, 2026

truCX Announces White Label Partnership with The Northridge Group

EIN Presswire

Mar. 3, 2026

VeeaVision AI for Real-Time Intelligent Visual Automation with IoT Data Fusion — Powered by TerraFabric™

GlobeNewswire

Mar. 3, 2026

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug

GlobeNewswire

Mar. 3, 2026

ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference

GlobeNewswire

Mar. 3, 2026

Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting

GlobeNewswire

Mar. 3, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026

GlobeNewswire

Mar. 3, 2026

Information relative au nombre total des droits de vote et d’actions composant le capital social au 28 février 2026

GlobeNewswire

Mar. 3, 2026

Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026

GlobeNewswire

Mar. 3, 2026

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire

Mar. 3, 2026

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

GlobeNewswire

Mar. 3, 2026

Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna

GlobeNewswire

Mar. 3, 2026

Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update

GlobeNewswire

Mar. 3, 2026

Rapid7 to Attend the Stifel 2026 NYC Technology One-on-One Conference

GlobeNewswire

Mar. 3, 2026

Orangekloud Technology Issues Update on Proposed Merger with VeVe

GlobeNewswire

Mar. 3, 2026

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

GlobeNewswire

Mar. 3, 2026

Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference

GlobeNewswire

Mar. 3, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire